SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-001384
Filing Date
2010-01-05
Accepted
2010-01-05 17:58:41
Documents
1
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4381
  Complete submission text file 0001209191-10-001384.txt   6215
Mailing Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075 (858) 480-0400
Somaxon Pharmaceuticals, Inc. (Issuer) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 12750 HIGH BLUFF DRIVE, SUITE 310 SAN DIEGO CA 92130
Business Address
Onaitis Matthew (Reporting) CIK: 0001362822 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51665 | Film No.: 10508788